AC Capital Partners
Search Fund
AC Capital Partners links business succession to the healthcare sector. Led by António Carvalho and based in Switzerland, it is interested in acquiring and managing a company in Switzerland or Portugal. Clinics, pharmacies, home care, and businesses related to health products or technology are part of the stated focus. Identity and succession proposal The website describes the initiative as an initially self-funded search and indicates that the formalisation of the entity is underway. These references should be read as information about the project itself, without concluding that the capital necessary for an acquisition is already committed. The identified responsible person is António Carvalho. The identity of this Swiss initiative should be kept distinct from Douro Partners, which also identifies a founder with the same name. For a business owner, the central question of this model is to understand who will lead the company after the sale. An acquisition led by an operator may allow for simultaneous negotiation of the change of ownership and the transfer of management. This possibility needs to be discussed with the specific buyer: the public profile explains the intention but does not fix the role of the seller, the future composition of the team, or the contractual conditions of the transition. Focus on health and related businesses AC Capital Partners' communication covers health services and activities related to technology, devices, and health products. Among the mentioned segments are clinics, pharmacies, home care, and companies linked to nutraceuticals. The presence of these segments in the thesis helps guide an initial analysis; it does not mean that all have the same framework, economic size, or requirements for an acquisition. A clinic and a device manufacturer may present similar revenues and very different risks. In the former, it is important to understand the stability of the clinical team, the origin of patients, and the dependence on specific professionals. In the latter, continuity of supply, ownership of technology, and development cycles may weigh more. These are preparation questions for the seller, not additional criteria assigned to AC Capital Partners. How to present a healthcare company A useful initial presentation should explain what the service or product is, who pays, and why they return to buy. In a clinical business, it is advisable to distinguish between individuals, insurers, companies, and other paying entities. In a technology activity, it is relevant to understand whether the revenue comes from licenses, subscriptions, maintenance, or projects. This separation allows for discussion of the predictability of the business without reducing different realities to a single revenue number. It also helps to show the difference between the company's results and the owner's remuneration. If the founder accumulates management and technical activity, the replacement of both functions may have distinct costs. Making this situation transparent facilitates a conversation about continuity. It does not require disclosing patient names or sensitive information in an initial approach; detailed elements should only be shared when there is an appropriate process. Portugal and Switzerland in the same thesis The published geographical focus includes Portugal and Switzerland. For a Portuguese company, it is relevant to confirm where the decision will be made, who will accompany the local analysis, and what the operational presence will be after a potential acquisition. An international connection may be useful for discussing expansion or management experience, but it should not be presented as a guarantee of access to new markets, financing, or clients. If the business already works with foreign clients, the presentation can identify the distribution of revenue by country and the way the service is provided. If it operates only in Portugal, it is important to explain the local position and growth limits. There is no need to construct an artificial international narrative: a well-positioned company in a regional market can have valuable characteristics, as long as these are demonstrated with real data and business relationships. Team, continuity, and founder dependence In a healthcare company, the quality of the transition often depends on people who are not shareholders. It is advisable to understand which critical functions exist, how they are coordinated, and what autonomy there is to maintain operations. Information can be presented by functions, without exposing personal data. An organisation with clear procedures allows for a more precise discussion of leadership transfer than a generic description of an experienced team. The seller should also define what they want for themselves: to exit management, continue in a technical role, accompany a transition, or maintain a stake. These options are not equivalent. The flexibility announced by a succession project only gains substance when translated into responsibilities, timelines, and concrete conditions. The profile of AC Capital Partners should serve to initiate this evaluation, without anticipating an agreement that does not yet exist. Size and structure of the operation The financial ranges disclosed on the website can guide an initial conversation, but their meaning should be confirmed in the current version of the thesis. Revenue, EBITDA, company value, and invested capital are different measures. An amount related to demand does not equate to the price that can be paid for a company. It also does not allow for conclusions about how much will be financed by investors, the buyer, or other sources. In preparing the opportunity, it is useful to separate historical accounts from forecasts and identify investments already necessary for operations. Equipment, technology, and facility expansion can alter capital needs after purchase. This information helps to understand the total economic effort and discuss structural alternatives, keeping the business description distinct from price negotiation. What to confirm before proceeding The first conversation should confirm the current situation of the initiative, the segments actually considered, and the willingness to analyse a Portuguese company. It is also worth clarifying who will represent the buyer and how the eventual management transition will be organised. The publicly available information supports the framework in health and succession; it does not prove an offer, a completed acquisition, or the acceptance of any opportunity. To compare this profile with other buyers, the seller can use three simple questions: is there alignment with the sector, with the type of transition desired, and with the actual size of the business? The AC Capital Partners website is the reference for the project's own communication.
- Sectors:
- Healthcare
- Region of interest:
- Portugal
View acquisition criteria
Current availability not confirmed
Profile not yet managed by the team